NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, announced today the appointment of Retired United States Army ...

Q4 2024 Earnings Call Transcript March 11, 2025 Operator: Welcome to the SIGA Business Update Call. Before we turn the call ...

“It will be necessary, based on today’s results, to pursue alternative treatments for mpox and other orthopoxviruses.” Host and Disease Factors Were Not Associated with the Resolution of ...

Daniel Luckshire; Chief Financial Officer, Executive Vice President, Corporate Secretary; SIGA Technologies Inc Welcome to the CIA business update call. Before returning the call over to CIA ...

approved TPOXX for the treatment of a broad range of orthopoxviruses. This approval marked another important milestone in our efforts to expand access to TPOXX. Additionally, it coupled with the ...

LOS ANGELES, March 12, 2025 (GLOBE NEWSWIRE) — ACTG, a global clinical trials network focused on HIV and other infectious diseases, recently presented data demonstrating that tecovirimat did not ...